XML 219 R99.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Information - Schedule of Consolidated Statements of Operations (Details) - Operating Segments [Member] - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Revenue            
Total Clinics level revenue $ 4,316,132 $ 4,049,025 $ 12,238,875 $ 13,270,973    
Total Clinics level revenue         $ 16,592,109 $ 16,675,393
Operating expenses            
General and administrative expenses 610,629 65,093 2,015,056 2,034,074 2,688,157 3,056,702
Total Clinics level expenses 4,139,722 3,488,099 11,775,819 12,547,071 15,987,718 16,178,180
Adjusted Clinics EBITDA 176,410 560,926 463,056 723,902 604,391 497,213
Reconciliation of Adjusted Clinics EBITDA to net loss            
Depreciation and amortization 330,498 340,167 864,293 1,048,290 1,308,619 1,252,539
Gain on sale of business 467,049   467,049 (467,049)
Loss on debt extinguishment (689,411) (1,587,862) 16,105
Interest expense 559,111 1,254,149 1,385,891 2,801,491 3,098,237 2,538,710
Loss on debt modification         2,134,218 927,054
Beneficial conversion feature         4,137,261
Other income (expenses) (4,768) 4,768 (1,134)
Corporate general and administrative 1,813,078 2,923,029 5,499,364 6,046,125 8,733,195 6,419,585
Impairment expense         56,664
Net Loss (2,526,273) (3,489,326) (7,975,878) (10,297,539) (14,264,261) (14,792,907)
Service Revenue [Member]            
Revenue            
Total Clinics level revenue 3,138,670 2,969,748 9,074,965 9,735,585 12,188,526 11,879,934
Product Revenue [Member]            
Revenue            
Total Clinics level revenue 1,177,462 1,079,277 3,163,910 3,535,388 4,403,583 4,795,459
Cost of Service Revenue [Member]            
Operating expenses            
Cost of product revenue (exclusive of depreciation and amortization, shown separately below) 2,678,940 2,568,085 7,253,536 7,705,972 9,736,282 9,700,963
Cost of Product Revenue [Member]            
Operating expenses            
Cost of product revenue (exclusive of depreciation and amortization, shown separately below) $ 850,153 $ 854,921 $ 2,507,227 $ 2,807,025 $ 3,563,279 $ 3,420,515